Health Services Administration: News and Research on Treatment Outcome

MeSH tree: N04.761.559.590.800

FDA approves TNKase for acute ischemic stroke

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Uncovering inequalities in breast cancer immunotherapy access

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases. Black women are twice as likely as white women to be diagnosed with TNBC and 28% more likely to die ...

page 9 from 19